Orient Pharma Co., Ltd.
4166
Rank in Stocks
#17513
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global... Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
Share Price
$0.68132765
Last synced: 2026-11-10
Market Cap
$165.59M
Change (1 day)
-0.89%
Change (1 year)
-15.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Orient Pharma Co., Ltd. (4166)
Category
Healthcare
EPS for Orient Pharma Co., Ltd. (4166)
EPS as of June 2026 TTM: $0.03
According to Orient Pharma Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.03. At the end of 2025 the company had an EPS of $0.03, an increase over its 2024 EPS of $0.01.
EPS history for Orient Pharma Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.03 | 2.00% |
| 2025 | $0.03 | 96.58% |
| 2024 | $0.01 | 342.42% |
| 2023 | 0.00 | -167.35% |
| 2022 | 0.00 | -75.25% |
| 2021 | $-0.02 | -45.00% |
| 2020 | $-0.04 | -16.47% |
| 2019 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | 5,422.88% |
US
|
|
| $1.93 | 6,209.80% |
SE
|
|
| $6.91 | 22,494.77% |
FR
|
|
| $0.02 | -36.27% |
HK
|
|
| $2.71 | 8,755.56% |
IT
|
Questions about Orient Pharma Co., Ltd.'s earnings per share (EPS)
What is Orient Pharma Co., Ltd.'s earnings per share (EPS)?
Orient Pharma Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.03, as of Jun 2026.
What was Orient Pharma Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Orient Pharma Co., Ltd.'s earnings per share (EPS) was $0.03, 200.00% more than in 2024 ($0.01).
How has Orient Pharma Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Orient Pharma Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($0.03) and lowest in 2020 ($-0.04).
How does Orient Pharma Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Orient Pharma Co., Ltd.'s earnings per share (EPS) ($0.03) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.